Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06707129

Establishment of Precise Histological Evaluation Criteria for NASH Fibrosis Reversal

Sponsor: Beijing Municipal Administration of Hospitals

View on ClinicalTrials.gov

Summary

Collect confirmed cases of NAFLD patients and enroll them in the study. Select patients with NASH and fibrosis stage F2-4 confirmed by liver biopsy, and collect clinical and pathological data for relevant evaluation and definition. Establish a NASH "fibrosis reversal" pathological evaluation system, based on a new reversal standard, establish non-invasive alternative indicators, and observe indicators.

Official title: Establishment of Precise Histological Evaluation Criteria for Reversal of NASH Fibrosis

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

OBSERVATIONAL

Enrollment

50

Start Date

2024-08-01

Completion Date

2027-08-31

Last Updated

2024-11-27

Healthy Volunteers

No

Interventions

OTHER

life-style

The patients were given health education and lifestyle intervention guidance, followed by lifestyle adjustment for at least 1 year and no more than 3 years, and a second liver biopsy was performed to evaluate liver histological changes.

Locations (1)

Beijing Ditan Hospital, Capital Medical University

Beijing, Beijing Municipality, China